Dynamiker Biotechnology (Tianjin) Co., Ltd.

Company News >> News >> Home


The Official QR Code

Company News

Dynamiker’s Products Entering Africa

AddTime:2017-07-28 15:46:45    Source:Dynamiker Biotechnology (Tianjin) Co., Ltd.    Views:1077

                                 Along the Maritime Silk Route, Dynamiker’s Products Entering Africa:
 President Dr. Zhou Zeqi’s Investigation to Africa

Dynamiker Biotechnology’s innovative products have been introduced into Africa’s medical market this year since it entered the clinical application of the European and Middle East hospitals last year.

In response to President Xi Jinping’s great call for “Creating China-Africa Fate Community”, following closely national strategic planning of” One belt, One Road” as well as Tianjin’s ambitious goal of” Support Little-Giant Enterprises Developing China-Africa International Cooperation”,  Dynamiker’s President Dr. Zhou Zeqi together with Delegation of Tianjin’s Science and Technology’s Commission visited the healthcare institutions of Nigeria and South Africa in late August, which including Nigeria’s Lagos University Medicine School and affiliated teaching hospital and National Center for clinical microbiological analysis. Besides, they also visited Manenburg clinical healthcare facility in Cape Town South Africa, and etc. 


In this trip to Africa, Dr. Zhou fully discussed with the Africa’s relevant experts about the feasibility of China-Africa Healthcare Cooperation. Having known Dynamiker Biotechnology’s panel testing products of invasive fungal diseases, the Africa’s healthcare-related departments and hospital clinical institutions think highly of Dynamiker’s products, they also reach a consensus with Dynamiker on the establishment of strategic partnerships.

According to the statistics of UNAIDS, by the end of 2014, about 37 million people worldwide infected with HIV. Africa accounted for 11% of the world’s population whereas HIV carriers accounted for 71% of the World’s carriers. AIDS and its associated fatal fungal diseases have become major killers for African people’s health. Dynamiker Biotechnology’s early, rapid diagnosis of fungal diseases and fungal diseases’ antigen-antibody panel testing scheme can meet the urgent need of clinical diagnosis in Africa, which occupies an important position in accurate diagnosis &treatment markets of fungal diseases in Africa. 

Dr. Zhou’s investigation to Africa actually made significant progress. It is essential for promoting the clinical application of Dynamiker’s superior products in Africa.

Dynamiker Biotechnology will continue actively participating in the strategic cooperation of China-Africa medical treatment, contributing for the accurate diagnosis and treatment of AIDs and its associated fatal fungal diseases.